Memorial Sloan Kettering Cancer Center

A clinical trial led by Dr. Lee Jones, exercise scientist at Memorial Sloan Kettering Cancer Center (MSK), suggests that specific amounts of exercise by men with early-stage prostate cancer before surgery can meaningfully improve two key biomarkers associated with better outcomes. “To our knowledge, this is the first Phase 1a clinical trial of exercise therapy in individuals with any type of cancer diagnosis,” says Dr. Jones, who leads the Exercise Oncology Program at MSK. “We believe...that this clinical trial represents an important step forward in rigorous investigation of how exercise impacts the progression and spread of cancer." Learn more about the clinical trial: https://bit.ly/3ydshgL

According to a large retrospective study co-led by Memorial Sloan Kettering Cancer Center (MSK) and published in the Journal of Clinical Oncology, PTCy is an acceptable alternative to CNI-based prophylaxis in MUD HCT recipients and superior for MMUD HCT. These results will help improve minority donor participation in the National Marrow Donor Program registry. Learn more: https://lnkd.in/eiCFK6mM

Part of the work of Memorial Sloan Kettering Cancer Center (MSK)'s Patient and Family Advisory Council for Quality (PFACQ) is giving a voice to the experience of cancer treatment and survivorship. Recently, two PFACQ members were asked to join a panel discussion on "Building Belonging Body Inclusivity: My Body and My Health." They spoke about the physical changes they endured from their disease and treatments and how that has impacted their lives. The experiences they, and others, have shared about the impact of treatment helps MSK improve care and elevate patient voices. Learn more about MSK's PFACQ: https://bit.ly/3SkY1Hv

Staff Spotlight: Nicole Wood has been a social worker for 14 years, a field she says allows her to meet people where they are. “I wanted to make meaningful connections with people to better understand their challenges and how to make a positive impact,” she says. As a social worker at Memorial Sloan Kettering Cancer Center (MSK) for more than two years, Nicole has been able to partner with MSK patients and families facing a cancer diagnosis. “My role at MSK allows me to be a part of an interdisciplinary team, and connect with people when they experience challenges that a cancer diagnosis and treatment can bring," she says. In addition, Nicole shares that the training and experience of social workers at MSK has allowed her to provide specialized support and counseling to those seeking help.

A team led by Dr. Gaetano Rocco, a thoracic surgeon at Memorial Sloan Kettering Cancer Center (MSK), reported promising results in a clinical trial that tested a screening method known as “E-nose." The E-nose uses technology that can “smell” lung cancer in a person’s breath. "Chemicals called volatile organic compounds (VOCs) are emitted by cancer cells,” Dr. Rocco explains. “And they can be detected even at early stages of the disease.” The trial raises hopes that E-nose could become an important tool in detecting lung cancer because the approach is noninvasive, highly accurate, inexpensive — and may one day even be small enough to slip inside a clinician’s pocket. "E-nose could be a valuable addition to diagnosing and treating lung cancer,” he says, “and MSK’s expertise and leadership in the field means it’s the right place to make this a reality.” Learn more: https://bit.ly/4bONjjp

This #GivingDay, help support Memorial Sloan Kettering Cancer Center (MSK)'s work towards discovering the next seemingly impossible breakthrough and bring hope to people impacted by cancer. Today, your gift goes 3X further to fund cancer care and research that saves lives, not only today but for years to come. Learn more: https://bit.ly/4d38SxN

Memorial Sloan Kettering Cancer Center has been ranked the #2 cancer center in the nation, and #1 in the nation for urology care by U.S. News & World Report in its annual Best Hospitals listing. Learn more: https://bit.ly/4bLWGk7

New research from Memorial Sloan Kettering Cancer Center (MSK) includes developing a deep-learning model designed to aid challenging cancer diagnoses, identifying key regulators of infection-clearing immune cells, and shedding new light on the mechanical forces exerted by immune cells. Learn more: https://bit.ly/3S1iGjC

It's been a fantastic Staff Appreciation Week! 🎉 Join us in showing gratitude for the outstanding team at MSK and their collaborative work and contributions towards our mission of ending cancer for life.

For Jennifer Brosnan, an Associate Director for Content Operations at MSK, joining Cycle for Survival was initially a way to honor her aunt who died of leukemia. Jennifer was working as a television news producer when a friend invited her to hop on a stationary bike and join their Cycle for Survival team. Several years later, Jennifer landed a job at MSK and in a matter of months, she became captain of In It To Spin It, the MSK Marketing & Communication department’s Cycle for Survival team. Jennifer has participated in Cycle for Survival rides for 12 years and along the way, she and her team have raised more than $136,000 for rare cancer research, with 100% of every dollar going directly to MSK labs. Through her work, Jennifer makes regular visits to MSK labs and clinics for film shoots. She says that meeting researchers and seeing the results of her fundraising is one of the best parts of her job. “It’s truly a direct line of impact,” she says. “I feel lucky to be here.”